Recombinant Mouse P2RX1 Protein，His

P2RX1, or purinergic receptor P2X, ionotropic 1, is a member of the P2X receptor family, which are ATP-gated ion channels known to play crucial roles in various physiological and pathological processes. Research on P2RX1 is particularly significant due to its involvement in pain transmission, inflammation, and tissue injury responses. Increased expression or activity of P2RX1 has been implicated in several diseases, including chronic pain conditions and certain neurological disorders. As a receptor that mediates neurotransmission in both the central and peripheral nervous systems, P2RX1 is of great interest for drug development, with potential therapeutic strategies targeting its signaling pathways to alleviate pain or modulate inflammatory responses. The production and characterization of recombinant P2RX1 proteins provide valuable insights into its structure-function relationships, ligand-binding properties, and downstream signaling mechanisms. Utilizing techniques such as site-directed mutagenesis, crystallography, and electrophysiology, researchers aim to elucidate how variations in P2RX1 affect its pharmacological profiles. These studies not only enhance our fundamental understanding of P2RX1 biology but also pave the way for novel therapeutic approaches in treating conditions associated with P2RX1 dysregulation. Given the increasing recognition of purinergic signaling in health and disease, the investigation of P2RX1 as a potential therapeutic target remains a vibrant and evolving area of research.